Beyond behavior: neural and cognitive alterations in eating disorders-a systematic review
Abstract
BACKGROUND
Eating disorders (EDs), particularly Anorexia Nervosa (AN) and Bulimia Nervosa (BN), are complex psychiatric conditions marked by alterations in cognition, emotional regulation, and interoception. Accumulating evidence suggests that these behavioral features are underpinned by structural and functional brain abnormalities.
OBJECTIVE
This systematic review aims to synthesize recent neuroimaging findings, particularly resting-state functional MRI and functional connectivity studies on cognitive and neural alterations in eating disorders (EDs).
METHODS
Following PRISMA guidelines (PROSPERO: CRD42025648023), we systematically searched PubMed and APA PsycINFO for studies published between 2014 and 2024. Twelve studies met inclusion criteria and were assessed for quality and risk of bias using GRADE, RoB 2.0, and ROBINS-I tools. The included studies investigated both adolescent and adult populations, allowing consideration of developmental and illness stage-related aspects.
RESULTS
Altered brain activity and connectivity patterns were consistently reported in individuals with AN and BN, particularly in the cortico-striatal-thalamic system (CSTS), default mode network (DMN), and interhemispheric circuits. Cognitive flexibility deficits were associated with abnormal neural activation despite preserved behavioral performance, suggesting compensatory mechanisms. Insular dysfunction persisted after weight restoration, and altered responses to reward and social cues were…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.